Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pisters

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 5, 2017
Real-life use of Rivaroxaban in the Netherlands: data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registryR Pisters, S P G van Vugt, M A Brouwer, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 5, 2011
Feasibility of TEE-guided stroke risk assessment in atrial fibrillation-background, aims, design and baseline data of the TIARA pilot studyT Dinh, L H B Baur, R Pisters, et al.
BMC Geriatrics|January 22, 2026
Healthcare professionals' perspectives on prescribing DOACs to frail older patients; the DOAC-FRAIL questionnaireM J de Jong, A D H Brys, D Braeken, et al.
European Heart Journal Open|August 3, 2022
Determinants of label non-adherence to non-vitamin K oral anticoagulants in patients with newly diagnosed atrial fibrillationJ Seelig, E M Trinks-Roerdink, G Chu, et al.
NEJM Evidence|November 10, 2025
Zalunfiban at First Medical Contact for ST-Elevation Myocardial InfarctionA W J Van't Hof, C M Gibson, S A O F Rikken, et al.
Thrombosis Research|November 15, 2025
Predicting clinically relevant bleeding in new-onset atrial fibrillation patients initiating oral anticoagulant therapy: External validation of the AF-BLEED scoreS F B van der Horst, G Chu, J Seelig, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 5, 2017
Real-life use of Rivaroxaban in the Netherlands: data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registryR Pisters, S P G van Vugt, M A Brouwer, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 5, 2011
Feasibility of TEE-guided stroke risk assessment in atrial fibrillation-background, aims, design and baseline data of the TIARA pilot studyT Dinh, L H B Baur, R Pisters, et al.
BMC Geriatrics|January 22, 2026
Healthcare professionals' perspectives on prescribing DOACs to frail older patients; the DOAC-FRAIL questionnaireM J de Jong, A D H Brys, D Braeken, et al.
European Heart Journal Open|August 3, 2022
Determinants of label non-adherence to non-vitamin K oral anticoagulants in patients with newly diagnosed atrial fibrillationJ Seelig, E M Trinks-Roerdink, G Chu, et al.
NEJM Evidence|November 10, 2025
Zalunfiban at First Medical Contact for ST-Elevation Myocardial InfarctionA W J Van't Hof, C M Gibson, S A O F Rikken, et al.
Thrombosis Research|November 15, 2025
Predicting clinically relevant bleeding in new-onset atrial fibrillation patients initiating oral anticoagulant therapy: External validation of the AF-BLEED scoreS F B van der Horst, G Chu, J Seelig, et al.
Pageof 2